Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase II Randomized, Observer-Blind, Placebo-Controlled, Study to Evaluate the Safety and Immunogenicity of a Respiratory Syncytial Virus (RSV) F Nanoparticle Vaccine With Aluminum, in Healthy Third-trimester Pregnant Women and to Assess the Impact of Maternal Immunization on Infant Safety Through One Year of Life
Brief Summary: The purpose of this study is to evaluate the safety and immunogenicity of an RSV-F protein nanoparticle vaccine, with aluminum, in healthy third-trimester pregnant women and to assess the impact of maternal immunization on infant safety through one year of life.


Options:
A: Arm Label: RSV LID ΔM2-2 Vaccine; Type: EXPERIMENTAL; Interventions: Biological: RSV LID ΔM2-2 Vaccine | Arm Label: Placebo Vaccine; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo Vaccine | Intervention Type: BIOLOGICAL; Name: RSV LID ΔM2-2 Vaccine; Assigned to Arm(s): RSV LID ΔM2-2 Vaccine | Intervention Type: BIOLOGICAL; Name: Placebo Vaccine; Assigned to Arm(s): Placebo Vaccine
B: Arm Label: RSV group; Type: EXPERIMENTAL; Interventions: Biological: RSV vaccine GSK3003891A | Arm Label: Boostrix group; Type: ACTIVE_COMPARATOR; Interventions: Biological: Boostrix | Intervention Type: BIOLOGICAL; Name: RSV vaccine GSK3003891A; Assigned to Arm(s): RSV group | Intervention Type: BIOLOGICAL; Name: Boostrix; Assigned to Arm(s): Boostrix group
C: Arm Label: Treatment Group A; Type: PLACEBO_COMPARATOR; Interventions: Drug: Saline Placebo (0.5mL injection) | Arm Label: Treatment Group B; Type: EXPERIMENTAL; Interventions: Drug: RSV F vaccine (0.5mL injection) | Intervention Type: DRUG; Name: Saline Placebo (0.5mL injection); Assigned to Arm(s): Treatment Group A | Intervention Type: DRUG; Name: RSV F vaccine (0.5mL injection); Assigned to Arm(s): Treatment Group B
D: Arm Label: RSV F 45 No Adj Group; Type: EXPERIMENTAL; Interventions: Biological: RSV F subunit 45 μg No adjuvant | Arm Label: RSV F 45 Alum Adj Group; Type: EXPERIMENTAL; Interventions: Biological: RSV F subunit 45 μg Aluminum hydroxide adjuvant | Arm Label: RSV F 45 MF59 Adj Group; Type: EXPERIMENTAL; Interventions: Biological: RSV F subunit 45 μg MF59 adjuvant | Arm Label: Placebo 1 Group; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: RSV F 90 No Adj Group; Type: EXPERIMENTAL; Interventions: Biological: RSV F subunit 90 μg No adjuvant | Arm Label: RSV F 90 Alum Adj Group; Type: EXPERIMENTAL; Interventions: Biological: RSV F subunit 90 μg Aluminum hydroxide adjuvant | Arm Label: RSV F 90 MF59 Adj Group; Type: EXPERIMENTAL; Interventions: Biological: RSV F subunit 90 μg MF59 adjuvant | Arm Label: Placebo 2 Group; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: RSV F 135 No Adj Group; Type: EXPERIMENTAL; Interventions: Biological: RSV F subunit 135 μg No adjuvant | Arm Label: RSV F 135 Alum Adj Group; Type: EXPERIMENTAL; Interventions: Biological: RSV F subunit 135 μg Aluminum hydroxide adjuvant | Arm Label: RSV F 135 MF59 Adj Group; Type: EXPERIMENTAL; Interventions: Biological: RSV F subunit 135 μg MF59 adjuvant | Arm Label: Placebo 3 Group; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: BIOLOGICAL; Name: RSV F subunit 45 μg No adjuvant; Assigned to Arm(s): RSV F 45 No Adj Group | Intervention Type: BIOLOGICAL; Name: RSV F subunit 45 μg Aluminum hydroxide adjuvant; Assigned to Arm(s): RSV F 45 Alum Adj Group | Intervention Type: BIOLOGICAL; Name: RSV F subunit 45 μg MF59 adjuvant; Assigned to Arm(s): RSV F 45 MF59 Adj Group | Intervention Type: BIOLOGICAL; Name: RSV F subunit 90 μg No adjuvant; Assigned to Arm(s): RSV F 90 No Adj Group | Intervention Type: BIOLOGICAL; Name: RSV F subunit 90 μg Aluminum hydroxide adjuvant; Assigned to Arm(s): RSV F 90 Alum Adj Group | Intervention Type: BIOLOGICAL; Name: RSV F subunit 90 μg MF59 adjuvant; Assigned to Arm(s): RSV F 90 MF59 Adj Group | Intervention Type: BIOLOGICAL; Name: RSV F subunit 135 μg No adjuvant; Assigned to Arm(s): RSV F 135 No Adj Group | Intervention Type: BIOLOGICAL; Name: RSV F subunit 135 μg Aluminum hydroxide adjuvant; Assigned to Arm(s): RSV F 135 Alum Adj Group | Intervention Type: BIOLOGICAL; Name: RSV F subunit 135 μg MF59 adjuvant; Assigned to Arm(s): RSV F 135 MF59 Adj Group | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo 1 Group, Placebo 2 Group, Placebo 3 Group

Answer: C